Sperm protein 17: Clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond

Maurizio Chiriva-Internati

doi:10.3109/08830185.2011.569903

Sperm protein 17: Clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond

Maurizio Chiriva-Internati

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

Sperm protein 17 belongs to the cancer/testis antigen family and was found to play a key role in the cell fusion process between the mammalian spermatozoa and egg. Sperm protein 17-specific autoantibodies in vasectomized males suggest its high expression in the testis. Sperm protein 17 expression levels are low or absent in normal tissues, other than the testis. Sperm protein 17 is expressed by tumors, including ovarian cancer, indicating that it is an ideal target for cancer immunotherapy, and plays a role in tumorigenesis and drug resistance. This review recapitulates the milestones of sperm protein 17 research and highlights its potential use in translational medicine.

Original language	English (US)
Pages (from-to)	138-149
Number of pages	12
Journal	International Reviews of Immunology
Volume	30
Issue number	2-3
DOIs	https://doi.org/10.3109/08830185.2011.569903
State	Published - Apr 2011
Externally published	Yes

Keywords

Sperm protein 17
cancer/testis antigens
cell contact
fertility
oncogenesis
ovarian cancer

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.3109/08830185.2011.569903

Cite this

@article{7f60c3e2c1c847929fb2e6534405949a,

title = "Sperm protein 17: Clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond",

abstract = "Sperm protein 17 belongs to the cancer/testis antigen family and was found to play a key role in the cell fusion process between the mammalian spermatozoa and egg. Sperm protein 17-specific autoantibodies in vasectomized males suggest its high expression in the testis. Sperm protein 17 expression levels are low or absent in normal tissues, other than the testis. Sperm protein 17 is expressed by tumors, including ovarian cancer, indicating that it is an ideal target for cancer immunotherapy, and plays a role in tumorigenesis and drug resistance. This review recapitulates the milestones of sperm protein 17 research and highlights its potential use in translational medicine.",

keywords = "Sperm protein 17, cancer/testis antigens, cell contact, fertility, oncogenesis, ovarian cancer",

author = "Maurizio Chiriva-Internati",

note = "Funding Information: This work was supported by the Billy and Ruby Power Endowment for Cancer Research and Laura W. Bush Institute for Women{\textquoteright}s Health and the Associate Dean of the Oncology Programs at TTUHSC. The author wishes to thank Teri Fields for her assistance in editing this manuscript.",

year = "2011",

month = apr,

doi = "10.3109/08830185.2011.569903",

language = "English (US)",

volume = "30",

pages = "138--149",

journal = "International Reviews of Immunology",

issn = "0883-0185",

publisher = "Informa Healthcare",

number = "2-3",

}

TY - JOUR

T1 - Sperm protein 17

T2 - Clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond

AU - Chiriva-Internati, Maurizio

N1 - Funding Information: This work was supported by the Billy and Ruby Power Endowment for Cancer Research and Laura W. Bush Institute for Women’s Health and the Associate Dean of the Oncology Programs at TTUHSC. The author wishes to thank Teri Fields for her assistance in editing this manuscript.

PY - 2011/4

Y1 - 2011/4

N2 - Sperm protein 17 belongs to the cancer/testis antigen family and was found to play a key role in the cell fusion process between the mammalian spermatozoa and egg. Sperm protein 17-specific autoantibodies in vasectomized males suggest its high expression in the testis. Sperm protein 17 expression levels are low or absent in normal tissues, other than the testis. Sperm protein 17 is expressed by tumors, including ovarian cancer, indicating that it is an ideal target for cancer immunotherapy, and plays a role in tumorigenesis and drug resistance. This review recapitulates the milestones of sperm protein 17 research and highlights its potential use in translational medicine.

AB - Sperm protein 17 belongs to the cancer/testis antigen family and was found to play a key role in the cell fusion process between the mammalian spermatozoa and egg. Sperm protein 17-specific autoantibodies in vasectomized males suggest its high expression in the testis. Sperm protein 17 expression levels are low or absent in normal tissues, other than the testis. Sperm protein 17 is expressed by tumors, including ovarian cancer, indicating that it is an ideal target for cancer immunotherapy, and plays a role in tumorigenesis and drug resistance. This review recapitulates the milestones of sperm protein 17 research and highlights its potential use in translational medicine.

KW - Sperm protein 17

KW - cancer/testis antigens

KW - cell contact

KW - fertility

KW - oncogenesis

KW - ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=79955861307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955861307&partnerID=8YFLogxK

U2 - 10.3109/08830185.2011.569903

DO - 10.3109/08830185.2011.569903

M3 - Article

C2 - 21557640

AN - SCOPUS:79955861307

SN - 0883-0185

VL - 30

SP - 138

EP - 149

JO - International Reviews of Immunology

JF - International Reviews of Immunology

IS - 2-3

ER -

Sperm protein 17: Clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this